In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci

Diagnostic Microbiology and Infectious Disease

Volumn 29, Issue 3, 1997, Pages 203-205

  Messick, Chad R ^a   Pendald, Susan L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG POTENTIATION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; UNITED STATES;

EID: 0343035280     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)81811-1     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention (1993) Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR 42:597-599.
2. Eliopoulos GM, Moellering RC, Jr. (1996) Antimicrobial combinations. In: Antibiotics in Laboratory Medicine, 4th ed. Ed, Lorian V. Baltimore, MD: Williams & Wilkins, pp. 330-396.
3. Johnson CC, Slavoski L, Schwartz M, May P, Pitsakis PG, Shur AL, Levison ME (1995) In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumonia and enterococci. Diagn Microbiol Infect Dis 21:169-173.
4. Kang SL, Rybak MJ (1995) Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model. Antimicrob Agents Chemother 39:1505-1511.
5. Lam S, Singer C, Tucci V, et al (1995) The challenge of vancomycin-resistant enterococci: A clinical and epidemiologic study. Am J Infect Control 23:170-180.
6. Lapointe J-R, Lavallée C, Michaud A, Chicoine L, Joncas J-H (1986) In vitro comparison of ampicillin-chloramphenicol and ampicillin-cefotaxime against 284 Haemophilus isolates. Antimicrob Agents Chemother 29: 594-597.
7. National Committee for Clinical Laboratory Standards (1993) Methods for Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically, 3rd Ed. Approved Standard. NCCLS Document M7-A3, Vol. 13, No. 25. Villanova, PA: National Committee for Clinical Laboratory Standards.
8. National Committee for Clinical Laboratory Standards (1995) Performance Standards for Antimicrobial Susceptibility Testing; 6th Informational Supplement. NCCLS Document M100-S6, Vol. 15, No. 14. Villanova, PA: National Committee for Clinical Laboratory Standards.
9. Norris AH, Reilly JP, Edelstein PH, Brennan PJ, Schuster MG (1995) Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin Infect Dis 20:1137-1144.
10. Rice LB, Carias LL (1994) RP 59500 (quinupristin/dalfopristin) in combination with other antimicrobials against multi-resistant E. faecalis and E. faecium, abstr. E100, p. 221. Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology.
11. Rocco V, Overturf G (1982) Chloramphenicol inhibition of the bactericidal effect of ampicillin against Haemophilus influenzae. Antimicrob Agents Chemother 21:349-351.
12. Schauf V, Green DC, Van Der Stuyf L, Riff L (1983) Chloramphenicol kills Haemophilus influenzae more rapidly than does ampicillin or cefamandole. Antimicrob Agents Chemother 23:364-368.
13. Wade J, Baillie L, Rolando N, Casewell M (1992) Pristinamycin for Enterococcus faecium resistant to vancomycin and gentamicin. Lancet 339:312-313.
14. Wade J, Rolando N, Casewell M (1991) Resistance of Enterococcus faecium to vancomycin and gentamicin. Lancet 337:1616.